Pubertal timing in children with Silver Russell syndrome compared to those born small for gestational age
- PMID: 36093089
- PMCID: PMC9451521
- DOI: 10.3389/fendo.2022.975511
Pubertal timing in children with Silver Russell syndrome compared to those born small for gestational age
Erratum in
-
Corrigendum: Pubertal timing in children with Silver Russell syndrome compared to those born small for gestational age.Front Endocrinol (Lausanne). 2023 Mar 15;14:1172736. doi: 10.3389/fendo.2023.1172736. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37008915 Free PMC article.
Abstract
Context: Data on pubertal timing in Silver Russell syndrome (SRS) are limited.
Design and methods: Retrospective observational study including twenty-three SRS patients [11p15 loss of methylation, (11p15 LOM, n=10) and maternal uniparental disomy of chromosome 7 (mUPD7, n=13)] and 21 small for gestational age (SGA). Clinical (thelarche in females; testis volume ≥ 4 ml in males; pubarche), BMI SD trend from the age of 5 to 9 years to the time of puberty, biochemical parameters of puberty onset [Luteinizing hormone (LH), 17-β-estradiol, testosterone], and bone age progression were evaluated.
Results: Pubertal onset and pubarche occurred significantly earlier in children with SRS than in SGA (p 0.03 and p 0.001, respectively) and clinical signs of puberty onset occurred earlier in mUPD7 than in 11p15LOM group (p 0.003). Five SRS children experienced central precocious puberty and LH, 17-β-estradiol, testosterone were detected earlier in SRS than in SGA (p 0.01; p 0.0001). Bone age delay in SRS children was followed by rapid advancement; the delta between bone age and chronological age in SRS group became significantly higher than in SGA group at the age of 9-11 years (p 0.007). 11p15LOM patients were underweight at the age of 5 years and showed a progressive normalization of BMI that was significantly higher than in mUPD7 (p 0.04) and SGA groups (p 0.03) at puberty onset.
Conclusion: Timing of puberty is affected in SRS and occurred earlier in mUPD7 compared to 11p15LOM. The impact of early puberty on adult height and metabolic status deserves long-term evaluation.
Keywords: 11p15 LOM; bone age; mUPD7; puberty; silver russell syndrome.
Copyright © 2022 Patti, Malerba, Calevo, Schiavone, Scaglione, Casalini, Russo, Fava, Bassi, Napoli, Allegri, D’Annunzio, Gastaldi, Maghnie and Di Iorgi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Gonadal function and pubertal development in patients with Silver-Russell syndrome.Hum Reprod. 2018 Nov 1;33(11):2122-2130. doi: 10.1093/humrep/dey286. Hum Reprod. 2018. PMID: 30252068
-
Long-Term Results of GH Treatment in Silver-Russell Syndrome (SRS): Do They Benefit the Same as Non-SRS Short-SGA?J Clin Endocrinol Metab. 2016 May;101(5):2105-12. doi: 10.1210/jc.2015-4273. Epub 2016 Mar 23. J Clin Endocrinol Metab. 2016. PMID: 27007691
-
The effects of 3-year growth hormone treatment and body composition in Polish patients with Silver-Russell syndrome.Endokrynol Pol. 2023;74(3):285-293. doi: 10.5603/EP.a2023.0042. Epub 2023 Jun 19. Endokrynol Pol. 2023. PMID: 37335065
-
Puberty in children born small for gestational age.Horm Res Paediatr. 2013;80(2):69-77. doi: 10.1159/000353759. Epub 2013 Jul 26. Horm Res Paediatr. 2013. PMID: 23899516 Review.
-
Clinical and Molecular Heterogeneity of Silver-Russell Syndrome and Therapeutic Challenges: A Systematic Review.Curr Pediatr Rev. 2023;19(2):157-168. doi: 10.2174/1573396318666220315142542. Curr Pediatr Rev. 2023. PMID: 35293298
Cited by
-
Comparison of the clinical characteristics of children with Silver-Russell syndrome genetically confirmed or not and their response to growth hormone therapy: a national multicenter study.J Pediatr Endocrinol Metab. 2025 May 28;38(8):830-837. doi: 10.1515/jpem-2024-0587. Print 2025 Aug 26. J Pediatr Endocrinol Metab. 2025. PMID: 40440520
-
Growth response of syndromic versus non-syndromic children born small for gestational age (SGA) to growth hormone therapy: a Belgian study.Front Endocrinol (Lausanne). 2023 Jun 2;14:1112938. doi: 10.3389/fendo.2023.1112938. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37334282 Free PMC article.